Grade 3 Hepatotoxicity following Fulvestrant, Palbociclib, and Erdafitinib Therapy in a Patient with ER-Positive/PR-Negative/HER2-Negative Metastatic Breast Cancer: A Case Report

Abstract O femeie în vârstă de 49 de ani cu cancer de sân metastatic ER-pozitiv/PR-negativ/HER2-negativ a prezentat hepatotoxicitate de gradul

Continue readingGrade 3 Hepatotoxicity following Fulvestrant, Palbociclib, and Erdafitinib Therapy in a Patient with ER-Positive/PR-Negative/HER2-Negative Metastatic Breast Cancer: A Case Report